This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • HIV/AIDS  • Immunization  • Women's Health  • Pregnancy and Breast Feeding  • Drug Therapy  • Adverse Effects  • Drug Therapy, Other  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Joan Stephenson, PhD

JAMA. 2008;299(13):1529-1530.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Boston—Analyses of results of a trial of a failed HIV vaccine have prompted some prominent scientists to urge the National Institutes of Health (NIH) to retreat from testing candidate vaccines of questionable value and to return to the laboratory to develop new approaches.

Whether or not the agency will move to scale back vaccine trials, scientists agree that with no prospect of an effective vaccine to curb the HIV/AIDS pandemic in the foreseeable future, expanding the repertoire of prevention tools is all the more important. New findings from studies of varying prevention strategies, including male circumcision and the use of antiretroviral drugs to curb HIV transmission during breastfeeding by mothers in resource-poor settings, were presented here at the 15th Conference on Retroviruses and Opportunistic Infections.

A STEP BACK FOR VACCINE RESEARCH

Scientists reported the results of analyses of data from the STEP trial, which tested a vaccine containing 3 genes from HIV . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?